Drugs / modified-diallyl disulfide oxide
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT03076320 | Mar 2017 → Jan 2019 | acne | University of Guadalajara | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | modified-diallyl disulfide oxide | “The other component of Zaxcell is modified-diallyl disulfide oxide (M-DDO) an antimicrobial and antiseptic agent” NCT03076320 ↗ |
| Known as | M-DDO | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03076320 ↗ |